212 related articles for article (PubMed ID: 33613429)
21. Status Epilepticus in Patients with Anti-NMDAR Encephalitis Requiring Intensive Care: A Follow-Up Study.
Wang X; Wan J; Wei Z; Song C; Kang X; Du F; Jiang W; Yang F
Neurocrit Care; 2022 Feb; 36(1):192-201. PubMed ID: 34286465
[TBL] [Abstract][Full Text] [Related]
22. Fibrinogen-to-albumin ratio percentage: An independent predictor of disease severity and prognosis in anti-N-methyl-D-aspartate receptor encephalitis.
Du J; Shao Y; Song Y; Wang K; Yang X; Li Y; Yao Y; Gong Z; Jia Y
Front Neurol; 2023; 14():1083752. PubMed ID: 36908596
[TBL] [Abstract][Full Text] [Related]
23. Catatonia in adult anti-NMDAR encephalitis: an observational cohort study.
Wu H; Wu C; Zhou Y; Huang S; Zhu S
BMC Psychiatry; 2023 Feb; 23(1):94. PubMed ID: 36750806
[TBL] [Abstract][Full Text] [Related]
24. Factors Affecting the Response to First-Line Treatments in Patients with Anti-N-Methyl-D-Aspartate Receptor Encephalitis.
Zhang X; Wang C; Zhu W; Wang B; Liang H; Guo S
J Clin Neurol; 2019 Jul; 15(3):369-375. PubMed ID: 31286710
[TBL] [Abstract][Full Text] [Related]
25. Anti-N-methyl-d-aspartate receptor encephalitis in children: Incidence and experience in Hong Kong.
Ho AC; Chan SH; Chan E; Wong SS; Fung ST; Cherk SW; Fung EL; Ma KH; Tsui KW; Yau EK; Wong VC
Brain Dev; 2018 Jun; 40(6):473-479. PubMed ID: 29599011
[TBL] [Abstract][Full Text] [Related]
26. Paroxysmal Sympathetic Hyperactivity in Severe Anti-N-Methyl-d-Aspartate Receptor Encephalitis: A Single Center Retrospective Observational Study.
Wang D; Su S; Tan M; Wu Y; Wang S
Front Immunol; 2021; 12():665183. PubMed ID: 33912193
[TBL] [Abstract][Full Text] [Related]
27. Thyroid Function and Autoimmune Indications in Patients with Anti-N-Methyl-D-Aspartate Receptor Encephalitis.
Ma X; Yin Q; Zeng Z; Wang C; Yang Y; Guo S
Neuroimmunomodulation; 2018; 25(2):110-117. PubMed ID: 30157483
[TBL] [Abstract][Full Text] [Related]
28. Emerging role of prodromal headache in patients with anti-N-methyl-D-aspartate receptor encephalitis.
Ma C; Wang C; Zhang Q; Lian Y
J Pain Res; 2019; 12():519-526. PubMed ID: 30787630
[TBL] [Abstract][Full Text] [Related]
29. Ofatumumab, a Fully Human Anti-CD20 Monoclonal Antibody, in the Treatment of Severe Refractory Anti-N-methyl-D-Aspartate Receptor Encephalitis: Two Case Reports.
Xue H; Jiang Y; Qin L; Wang X; Zhang M; Dai S; Teng Y; Xu J; Li W
Ann Indian Acad Neurol; 2023; 26(5):774-777. PubMed ID: 38022469
[TBL] [Abstract][Full Text] [Related]
30. Brain astrocytoma misdiagnosed as anti-NMDAR encephalitis: a case report.
Lu J; Zhang JH; Miao AL; Yin JX; Zhu DL; Lin XJ; Chen DW; Shi JP
BMC Neurol; 2019 Aug; 19(1):210. PubMed ID: 31462223
[TBL] [Abstract][Full Text] [Related]
31. Characterization and Outcomes of Epileptic Seizures in Mexican Pediatric Patients With Anti-N-Methyl-D-Aspartate Receptor Encephalitis.
Chavez-Castillo M; Ruiz-Garcia M; Herrera-Mora P
Cureus; 2020 May; 12(5):e8211. PubMed ID: 32577329
[TBL] [Abstract][Full Text] [Related]
32. Anti-N-methyl-D-aspartate receptor encephalitis with accompanying ovarian teratoma in female patients from East China: Clinical features, treatment, and prognostic outcomes.
Zhang L; Lu Y; Xu L; Liu L; Wu X; Zhang Y; Zhu G; Hong Z
Seizure; 2020 Feb; 75():55-62. PubMed ID: 31874360
[TBL] [Abstract][Full Text] [Related]
33. Neurocritical care for Anti-NMDA receptor encephalitis.
Lin KL; Lin JJ
Biomed J; 2020 Jun; 43(3):251-258. PubMed ID: 32330674
[TBL] [Abstract][Full Text] [Related]
34. A Case of Severe Anti-N-Methyl D-Aspartate (Anti-NMDA) Receptor Encephalitis with Refractory Autonomic Instability and Elevated Intracranial Pressure.
Salehi N; Yuan AK; Stevens G; Koshy R; Klein WF
Am J Case Rep; 2018 Oct; 19():1216-1221. PubMed ID: 30310049
[TBL] [Abstract][Full Text] [Related]
35. Surgical outcomes in patients with anti-N-methyl D-aspartate receptor encephalitis with ovarian teratoma.
Dai Y; Zhang J; Ren H; Zhou X; Chen J; Cui L; Lang J; Guan H; Sun D
Am J Obstet Gynecol; 2019 Nov; 221(5):485.e1-485.e10. PubMed ID: 31128109
[TBL] [Abstract][Full Text] [Related]
36. Anti-N-Methyl-D-Aspartate Receptor Encephalitis, A Diagnosis Not To Miss.
Valente T; Gonçalves G; Duarte V; Jesus G
Eur J Case Rep Intern Med; 2023; 10(8):003974. PubMed ID: 37554478
[TBL] [Abstract][Full Text] [Related]
37. Cerebrospinal fluid light and heavy neurofilament level increased in anti-N-methyl-d-aspartate receptor encephalitis.
Li J; Gu Y; An H; Zhou Z; Zheng D; Wang Z; Wen Z; Shen HY; Wang Q; Wang H
Brain Behav; 2019 Aug; 9(8):e01354. PubMed ID: 31313506
[TBL] [Abstract][Full Text] [Related]
38. Abnormal level of consciousness predicts outcomes of patients with anti-NMDA encephalitis.
Aungsumart S; Ha A; Apiwattanakul M
J Clin Neurosci; 2019 Apr; 62():184-187. PubMed ID: 30482402
[TBL] [Abstract][Full Text] [Related]
39. [Ovarian tumor associated with anti-N-methyl-D-aspartate receptor encephalitis: a report of 15 cases].
Li XM; Jiang HY; Wang YF; Qiu W; Wang Y; Wu HT
Zhonghua Yi Xue Za Zhi; 2017 Oct; 97(37):2932-2935. PubMed ID: 29050165
[No Abstract] [Full Text] [Related]
40. Associations between seizures and MRI in patients with anti-NMDAR encephalitis.
Ni G; Lin W; Cai X; Qin J; Feng L; Zhu S; Zhou L; Chen Z
Acta Neurol Scand; 2020 Nov; 142(5):460-465. PubMed ID: 32533702
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
